Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ginkgo Biloba and Glucosamine for Tinea Pedis
NCT02882438Phase 1Unknown
- Start
- Jan 2016
- Primary completion
- Sep 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised trial of ginkgo biloba extract and glucosamine sulphate in tinea pedis, tinea capitis and tinea versicolor (2 arms). Primary endpoint: Assessment the antifungal activity of Ginkgo Biloba & Glucosamine at 6 months. Status: unknown.
02
Drugs
ginkgo biloba extractglucosamine sulphate
03
Conditions
tinea pedistinea capitistinea versicolor
Beyond the preview
Go deeper on NCT02882438.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02882438.